Newsroom

Recent News Releases

February 15, 2019 2/15/2019 Shire's Full Year 2018 Results

February 15, 2019 2/15/2019 Notice Regarding Issue of Hybrid Bonds to replace Senior Short Term Loan (Offering of Subordinated Bonds)

February 11, 2019 2/11/2019 European Commission Approves ADCETRIS^® (brentuximab vedotin) with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

February 6, 2019 2/6/2019 Takeda announces results from first-of-its-kind phase IIIb/IV trial PROPEL – a randomized PK-guided prophylaxis study evaluating higher factor VIII levels in hemophilia A– at EAHAD 2019

February 4, 2019 2/4/2019 Takeda to Highlight Advancements in Rare Lysosomal Storage Disorders at Global Scientific Meeting

SEE ALL NEWS AND RELEASES >

・For legacy Shire information, click here

Featured Topics

Celebrating Our New Global Reach

LEARN MORE

Takeda’s Transformation: The Next Chapter

LEARN MORE

2019 Innovators in Science Award Winners Announced in Regenerative Medicine

LEARN MORE

Novel access solutions for novel medicines

LEARN MORE

Perspectives on confronting and embracing disruptions in healthcare

LEARN MORE

SEE ALL FEATURED TOPICS ARTICLES >

In the News

With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.

LEARN MORE

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber

LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.